Table 1.
Summary of patients’ characteristics by race
| N (%) | N (%) | N (%) | |||
|---|---|---|---|---|---|
| Characteristic | Total (N=3286) | White N= (2186) | Black N= (1100) | P | |
| Age (mean±SD) | 51.00 (7.64) | 51.44 (7.45) | 50.11 (7.92) | <0.01 | |
| Age categories | Under 45 years old | 594 (18.08) | 354 (16.19) | 240 (21.82) | <0.01 |
| 45–54 years old | 1512 (46.01) | 982 (44.92) | 530 (48.18) | ||
| 55–64 years old | 1180 (35.91) | 850 (38.88) | 330 (30.00) | ||
| Marital status | Not married | 1510 (45.95) | 827 (37.83) | 683 (62.09) | <0.01 |
| Married | 1776 (54.05) | 1359 (62.17) | 417 (37.91) | ||
| Rural/Urban status | Rural | 815 (24.80) | 477 (21.82) | 338 (30.73) | <0.01 |
| Urban | 2471 (75.20) | 1709 (78.18) | 762 (69.21) | ||
| Year of diagnosis | 2002–2004 | 994 (30.25) | 671 (30.70) | 323 (29.36) | 0.04 |
| 2005–2007 | 1020 (31.04) | 701 (32.07) | 319 (29.00) | ||
| 2008–2010 | 1272 (38.71) | 814 (37.24) | 458 (41.64) | ||
| Hormone receptor status | Negative | 512 (15.58) | 271 (12.40) | 241 (21.91) | <0.01 |
| Unknown | 1472 (44.80) | 974 (44.56) | 498 (45.27) | ||
| Positive | 1302 (39.62) | 941 (43.05) | 361 (32.28) | ||
| Stage at Diagnosis | In-situ | 555 (16.89) | 376 (17.20) | 179 (16.27) | <0.01 |
| Local | 1460 (44.43) | 1015 (46.43) | 445 (40.45) | ||
| Regional/Distant | 1232 (37.49) | 774 (35.41) | 458 (41.64) | ||
| Unknown | 39 (1.19) | (0.96) | 18 (1.64) | ||
| Cancer grade | I | 489 (14.88) | 367 (16.79) | 122 (11.09) | <0.01 |
| II | 1099 (33.44) | 799 (36.55) | 300 (27.27) | ||
| III | 1383 (42.09) | 801 (36.74) | 582 (52.91) | ||
| Unknown | 315 (9.59) | 219 (10.02) | 96 (8.73) | ||
| Best Chance Network | No | 3023 (92.00) | 2061 (94.28) | 962 (87.45) | <0.01 |
| Yes | 263 (8.00) | 125 (5.72) | 138 (12.55) | ||
| Health Insurance* | 1 | 2043 (62.17) | 1558 (71.27) | 485 (44.09) | <0.01 |
| 2 | 1243 (37.83) | 628 (28.73) | 615 (55.91) |
*
As per data use agreement with data providers, the specific health insurance providers were masked